281 related articles for article (PubMed ID: 32247225)
21. Familial hyperparathyroidism: report of a case.
Abe H; Tani T; Naito H; Mekata E; Sako H; Ioka J; Kodama M
Surg Today; 1999; 29(1):63-6. PubMed ID: 9934834
[TBL] [Abstract][Full Text] [Related]
22. Parathyroid Carcinoma.
Cetani F; Pardi E; Marcocci C
Front Horm Res; 2019; 51():63-76. PubMed ID: 30641523
[TBL] [Abstract][Full Text] [Related]
23. Approach to the Patient With Parathyroid Carcinoma.
Cetani F; Pardi E; Torregrossa L; Borsari S; Pierotti L; Dinoi E; Marcocci C
J Clin Endocrinol Metab; 2023 Dec; 109(1):256-268. PubMed ID: 37531615
[TBL] [Abstract][Full Text] [Related]
24. Genetic defects associated with familial and sporadic hyperparathyroidism.
Hendy GN; Cole DE
Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
[TBL] [Abstract][Full Text] [Related]
25. Surgical treatment of parathyroid carcinoma (Review).
Hoelting T; Weber T; Werner J; Herfarth C
Oncol Rep; 2001; 8(4):931-4. PubMed ID: 11410812
[TBL] [Abstract][Full Text] [Related]
26. [Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].
Frank-Raue K; Leidig-Bruckner G; Lorenz A; Rondot S; Haag C; Schulze E; Büchler M; Raue F
Dtsch Med Wochenschr; 2011 Sep; 136(38):1889-94. PubMed ID: 21915802
[TBL] [Abstract][Full Text] [Related]
27. Parathyroid carcinoma in multiple endocrine neoplasm type 1 syndrome: case report and systematic literature review.
Di Meo G; Sgaramella LI; Ferraro V; Prete FP; Gurrado A; Testini M
Clin Exp Med; 2018 Nov; 18(4):585-593. PubMed ID: 29922966
[TBL] [Abstract][Full Text] [Related]
28. Hyperparathyroidism-jaw tumor syndrome.
Kutcher MR; Rigby MH; Bullock M; Trites J; Taylor SM; Hart RD
Head Neck; 2013 Jun; 35(6):E175-7. PubMed ID: 22302605
[TBL] [Abstract][Full Text] [Related]
29. Familial parathyroid tumors: diagnosis and management.
Stålberg P; Carling T
World J Surg; 2009 Nov; 33(11):2234-43. PubMed ID: 19184636
[TBL] [Abstract][Full Text] [Related]
30. [Parathyroid carcinoma. Therapeutic strategies derived from 20 years of experience].
Pelizzo MR; Piotto A; Bergamasco A; Rubello D; Casara D
Minerva Endocrinol; 2001 Mar; 26(1):23-9. PubMed ID: 11323564
[TBL] [Abstract][Full Text] [Related]
31. Parathyroid cancer.
Sharretts JM; Kebebew E; Simonds WF
Semin Oncol; 2010 Dec; 37(6):580-90. PubMed ID: 21167377
[TBL] [Abstract][Full Text] [Related]
32. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
33. Recurrence of Hyperparathyroid Hypercalcemia in a Patient With the HRPT-2 Mutation and a Previous Parathyroid Carcinoma in Hyperparathyroidism-Jaw Tumor Syndrome.
Mele M; Rolighed L; Jespersen M; Rejnmark L; Christiansen P
Int J Endocrinol Metab; 2016 Apr; 14(2):e35424. PubMed ID: 27679651
[TBL] [Abstract][Full Text] [Related]
34. [CDC73 mutations in young patients with primary hyperparathyroidism: A description of two clinical cases].
Mamedova EO; Mokrysheva NG; Pigarova EA; Przhiyalkovskaya EG; Voronkova IA; Vasilyev EV; Petrov VM; Gorbunova VA; Rozhinskaya LY; Belaya ZE; Tyulpakov AN
Ter Arkh; 2016; 88(10):57-62. PubMed ID: 27801421
[TBL] [Abstract][Full Text] [Related]
35. Clinical and genetic analysis of atypical parathyroid adenoma compared with parathyroid carcinoma and benign lesions in a Chinese cohort.
Chen Y; Song A; Nie M; Jiang Y; Li M; Xia W; Wang O; Xing X
Front Endocrinol (Lausanne); 2023; 14():1027598. PubMed ID: 36777354
[TBL] [Abstract][Full Text] [Related]
36. MAJOR MOLECULAR GENETIC DRIVERS IN SPORADIC PRIMARY HYPERPARATHYROIDISM.
Arnold A
Trans Am Clin Climatol Assoc; 2016; 127():235-244. PubMed ID: 28066056
[TBL] [Abstract][Full Text] [Related]
37. CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.
van der Tuin K; Tops CMJ; Adank MA; Cobben JM; Hamdy NAT; Jongmans MC; Menko FH; van Nesselrooij BPM; Netea-Maier RT; Oosterwijk JC; Valk GD; Wolffenbuttel BHR; Hes FJ; Morreau H
J Clin Endocrinol Metab; 2017 Dec; 102(12):4534-4540. PubMed ID: 29040582
[TBL] [Abstract][Full Text] [Related]
38. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
Bricaire L; Odou MF; Cardot-Bauters C; Delemer B; North MO; Salenave S; Vezzosi D; Kuhn JM; Murat A; Caron P; Sadoul JL; Silve C; Chanson P; Barlier A; Clauser E; Porchet N; Groussin L;
J Clin Endocrinol Metab; 2013 Feb; 98(2):E403-8. PubMed ID: 23293331
[TBL] [Abstract][Full Text] [Related]
39. [An update on parathyroid carcinoma].
Barberán M; Campusano C; Salman P; Trejo P; Silva-Figueroa A; Rivera S; Florenzano P; Velasco S; Illanes F; Trincado P; Canessa J; Solar A; Moreno M; Eugenin D; Jiménez B; Arroyo P
Rev Med Chil; 2021 Mar; 149(3):399-408. PubMed ID: 34479319
[TBL] [Abstract][Full Text] [Related]
40. Hyperparathyroidism in hereditary syndromes: special expressions and special managements.
Marx SJ; Simonds WF; Agarwal SK; Burns AL; Weinstein LS; Cochran C; Skarulis MC; Spiegel AM; Libutti SK; Alexander HR; Chen CC; Chang R; Chandrasekharappa SC; Collins FS
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N37-43. PubMed ID: 12412776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
